Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1321910

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1321910

Global Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product(Chemical intermediates, Bulk drug intermediates), By Application(Analgesics, Anti-inflammatory drug) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
Single User License
USD 5300
Multiple User License
USD 6200
Enterprise License
USD 7100

Add to Cart

Global Pharmaceutical Intermediates Market size was valued at USD 29 billion in 2021 and is poised to grow from USD 30.6 billion in 2022 to USD 52.6 billion by 2030, growing at a CAGR of 6.3% in the forecast period (2023-2030).

Pharmaceutical intermediates play a crucial role as raw materials in the production of bulk drugs. These intermediates are formed during the synthesis of active pharmaceutical ingredients (APIs) before further processing. They are derived from high-quality basic ingredients and find extensive applications in the pharmaceutical and cosmetic industries. The global market for pharmaceutical intermediates is experiencing growth due to the rising demand in these sectors, particularly for research and development purposes.

These intermediates are essential in the manufacturing of various products, including pesticides, drugs, resins, additives, plasticizers, and more, using materials like coal tar or petroleum. The market's expansion is primarily driven by the increased production of active pharmaceutical ingredients, responding to the growing demand for advanced therapies with improved delivery systems and personalized medicines worldwide.

Despite the positive outlook, the industry faces challenges such as the high cost of acquiring biopharmaceutical drugs and substantial apital investments required for API production. However, the introduction of new technologies in pharmaceutical manufacturing and increased investment in research activities are expected to create promising growth opportunities in the coming years.

Segments covered in this report:

Global pharmaceutical intermediates market is segmented on the basis of product, application, and region. On the basis of product, global market is segmented into chemical intermediates, bulk drug intermediates and custom intermediates. On the basis of application, global market is segmented into, analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs and anti-cancer drugs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The rising prevalence of chronic diseases and the global aging population are significant factors contributing to an increased demand for drug formulations to manage these conditions. According to the World Health Organization (WHO), the cases of diabetes have escalated from 108.0 million in 1980 to 422.0 million in 2014, with a continuous upward trend. Additionally, the WHO predicts a 57% increase in the incidence of chronic diseases by 2020, signifying a substantial portion of the population being affected by these conditions. As a result, the pharmaceutical market is witnessing growth during the forecast period due to these driving factors.

Restraint

The global pharmaceutical intermediates market faces challenges to its growth due to two significant factors. Firstly, the high expenses associated with acquiring biopharmaceutical drugs act as a major hindrance. Secondly, the substantial capital investment required for the production of active pharmaceutical ingredients (APIs) serves as a significant restraint that could impede the market's growth.

Market Trends

The cost incurred by the nation's healthcare system due to heart disease is on the rise. An important trend observed in the pharmaceutical intermediates market is the increasing prevalence of chronic cardiovascular conditions like heart failure and coronary artery disease. A July 2020 paper published in the Curious Journal of Medical Science states that ischemic heart disease (IHD) ranks as the leading cause of death worldwide. Approximately 126 million people globally are affected by ischemic heart disease. The projections indicate that by 2030, there will be over 1,845 cases of ischemic heart disease per 100,000 individuals worldwide.

Product Code: SQMIG35I2111

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Pharmaceutical Intermediates Market by Product

  • Market Overview
  • Chemical intermediates
  • Bulk drug intermediates
  • and Custom intermediates

Global Pharmaceutical Intermediates Market by Application

  • Market Overview
  • Analgesics
  • Anti-inflammatory drug
  • Cardiovascular drugs
  • Anti-diabetic drugs
  • Anti-cancer drugs

Global Pharmaceutical Intermediates Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • BASF SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wuxi AppTec Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dishman Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Codexis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cambrex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hikal Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chemcon Speciality Chemicals Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Porton Fine Chemicals Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Divis Laboratories Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer CentreOne
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aurobindo Pharma Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lianhe Chemical Technology Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jiangsu Hengrui Medicine Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shandong Xinhua Pharmaceutical Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi STA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhejiang NHU Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!